Kazuno Omori

Favorable effect of sodium–glucose cotransporter 2 inhibitor, dapagliflozin, on non‐alcoholic fatty liver disease compared with pioglitazone

Kyu Yong Cho, Akinobu Nakamura, Kazuno Omori et al. · Journal of Diabetes Investigation · 2020 · 55 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Effects of dapagliflozin and/or insulin glargine on beta cell mass and hepatic steatosis in db/db mice

Kazuno Omori, Akinobu Nakamura, Hideaki Miyoshi et al. · Metabolism · 2019 · 37 citations

Medicine, Endocrinology, Pharmacology +17

Effect of the sodium–glucose cotransporter 2 inhibitor luseogliflozin on pancreatic beta cell mass in db/db mice of different ages

Kiyohiko Takahashi, Akinobu Nakamura, Hideaki Miyoshi et al. · Scientific Reports · 2018 · 35 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Glucokinase Inactivation Paradoxically Ameliorates Glucose Intolerance by Increasing β-Cell Mass in <i>db/db</i> Mice

Kazuno Omori, Akinobu Nakamura, Hideaki Miyoshi et al. · Diabetes · 2021 · 24 citations · Full text

Medicine, Endocrinology, Molecular Biology +17

Simultaneous production of96Tc and111In by α-particle irradiation of stacked Nb and Ag foils, and their carrier-free separations

Takashi Omori, Kazuno Omori, C. Ochi et al. · Journal of Radioanalytical and Nuclear Chemistry · 1984 · 20 citations

Natural Sciences, Chemistry, Materials Science +9